Authors: RAPTOPOULOUGIGI M

Citation: M. Raptopoulougigi, WHEN AND HOW SHOULD DIALYSIS PATIENTS WITH ANTI-HEPATITIS-C ANTIBODIES BE TREATED, Seminars in dialysis, 10(5), 1997, pp. 257-258

Authors: GARYFALLOS A RAPTOPOULOUGIGI M ORPHANOU H SPAIA S PETRIDOU P VAYIONAS G

Citation: A. Garyfallos et al., INTERLEUKIN 2-DEPENDENT IMMUNOREGULATORY FUNCTION IN HEMODIALYSIS-PATIENTS WITH CHRONIC HEPATITIS-C, Journal of investigational allergology & clinical immunology, 5(5), 1995, pp. 255-258

Authors: RAPTOPOULOUGIGI M SPAIA S GARIFALLOS A XENOU P ORPHANOU H ZARAFIDOU E PETRIDOU P VRETTOU H VAGIONAS G GALAKTIDOU G MAVROUDI I EFKARPIDOU A KORTSARIS A

Citation: M. Raptopoulougigi et al., INTERFERON-ALPHA-2B TREATMENT OF CHRONIC HEPATITIS-C IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1834-1837

Authors: RAPTOPOULOUGIGI M ORPHANOUKOUMERKERIDOU H

Citation: M. Raptopoulougigi et H. Orphanoukoumerkeridou, THE EFFECT OF INTERFERON ON ACTIVATED PERIPHERAL-BLOOD T-LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS-B, Immunopharmacology and immunotoxicology, 16(4), 1994, pp. 577-588

Authors: PRINTZIS S RAPTOPOULOUGIGI M ORPHANOUKOUMERKERIDOU H LAGRE F GOULIS G

Citation: S. Printzis et al., IMMUNOTHERAPY IN CHRONIC BRUCELLOSIS - EFFECT OF LEVAMISOLE AND INTERFERON - MECHANISMS OF ACTION AND CLINICAL-VALUE, Immunopharmacology and immunotoxicology, 16(4), 1994, pp. 679-693

Authors: RAPTOPOULOUGIGI M ILONIDIS G ORPHANOUKOUMERKERIDOU H PREPONIS C SIDIROPOULOS J LAZARIDIS T GOULIS G

Citation: M. Raptopoulougigi et al., THE EFFECT OF LORATADINE ON ACTIVATED CELLS OF THE NASAL-MUCOSA IN PATIENTS WITH ALLERGIC RHINITIS, Journal of investigational allergology & clinical immunology, 3(4), 1993, pp. 192-197